HOFBF
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Jul 7 closing price
Capitalization
68.85M
KROS
Price
$15.59
Change
+$0.04 (+0.26%)
Updated
Sep 5 closing price
Capitalization
633.19M
54 days until earnings call
Interact to see
Advertisement

HOFBF vs KROS

Header iconHOFBF vs KROS Comparison
Open Charts HOFBF vs KROSBanner chart's image
Hofseth Biocare ASA
Price$0.17
Change+$0.01 (+6.25%)
Volume$10K
Capitalization68.85M
Keros Therapeutics
Price$15.59
Change+$0.04 (+0.26%)
Volume$537.58K
Capitalization633.19M
HOFBF vs KROS Comparison Chart in %
Loading...
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOFBF vs. KROS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOFBF is a Hold and KROS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HOFBF: $0.17 vs. KROS: $15.59)
Brand notoriety: HOFBF and KROS are both not notable
HOFBF represents the Food: Major Diversified, while KROS is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOFBF: 104% vs. KROS: 119%
Market capitalization -- HOFBF: $68.85M vs. KROS: $633.19M
HOFBF [@Food: Major Diversified] is valued at $68.85M. KROS’s [@Biotechnology] market capitalization is $633.19M. The market cap for tickers in the [@Food: Major Diversified] industry ranges from $241.32B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Food: Major Diversified] industry is $7.14B. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOFBF’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • HOFBF’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than HOFBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOFBF’s TA Score shows that 1 TA indicator(s) are bullish while KROS’s TA Score has 6 bullish TA indicator(s).

  • HOFBF’s TA Score: 1 bullish, 0 bearish.
  • KROS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KROS is a better buy in the short-term than HOFBF.

Price Growth

HOFBF (@Food: Major Diversified) experienced а 0.00% price change this week, while KROS (@Biotechnology) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Food: Major Diversified industry was -0.34%. For the same industry, the average monthly price growth was +2.49%, and the average quarterly price growth was +895.28%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Food: Major Diversified (-0.34% weekly)

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($633M) has a higher market cap than HOFBF($68.9M). HOFBF YTD gains are higher at: 66.600 vs. KROS (-1.516). KROS has higher annual earnings (EBITDA): 25.5M vs. HOFBF (-73.54M). KROS has more cash in the bank: 690M vs. HOFBF (71.9M). KROS has less debt than HOFBF: KROS (18M) vs HOFBF (236M). HOFBF has higher revenues than KROS: HOFBF (266M) vs KROS (233M).
HOFBFKROSHOFBF / KROS
Capitalization68.9M633M11%
EBITDA-73.54M25.5M-288%
Gain YTD66.600-1.516-4,393%
P/E RatioN/A48.72-
Revenue266M233M114%
Total Cash71.9M690M10%
Total Debt236M18M1,311%
FUNDAMENTALS RATINGS
HOFBF: Fundamental Ratings
HOFBF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HOFBFKROS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
15%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
13%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
32%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRIDX75.350.62
+0.83%
T. Rowe Price International Discovery
NMIEX13.40N/A
N/A
Northern Active M International Equity
IASMX18.45N/A
N/A
Guinness Atkinson Asia Focus
MSCGX11.83N/A
N/A
Mercer US Small/Mid Cap Equity Y3
CVQZX9.37N/A
N/A
Columbia Disciplined Value Inst

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been closely correlated with ACHV. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOFBF jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
ACHV - HOFBF
72%
Closely correlated
+1.43%
COGT - HOFBF
63%
Loosely correlated
+0.85%
KROS - HOFBF
38%
Loosely correlated
+0.26%
XFOR - HOFBF
35%
Loosely correlated
-3.85%
UNBX - HOFBF
33%
Loosely correlated
+22.90%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.26%
INO - KROS
52%
Loosely correlated
+1.45%
ANAB - KROS
41%
Loosely correlated
+3.84%
DNLI - KROS
39%
Loosely correlated
+4.33%
XNCR - KROS
38%
Loosely correlated
+2.15%
ALT - KROS
38%
Loosely correlated
+6.18%
More